CryoLife, Inc. (CRY) Receives Conditional IDE Approval to Begin Clinical Trials for PerClot® in the U.S.
6/19/2013 11:07:08 AM
More...
|
CryoLife, Inc. (CRY) Receives CE Mark for HeRo® Graft
6/10/2013 7:00:59 AM
More...
|
CryoLife, Inc. (CRY) Increases Quarterly Cash Dividend 10 Percent for the Second Quarter 2013
5/28/2013 7:35:32 AM
More...
|
CryoLife, Inc. (CRY) 2013 First Quarter Revenues Grew 10 Percent to a Record $35.5 Million
4/30/2013 7:25:11 AM
More...
|
CryoLife, Inc. (CRY) Announces Release Date and Teleconference Call Details for 2013 First Quarter Financial Results
4/9/2013 6:54:35 AM
More...
|
CryoLife, Inc. (CRY) to Host Central Venous Pathology Summit
4/8/2013 7:27:11 AM
More...
|
CryoLife, Inc. (CRY) Receives FDA Clearance for Next Generation HeRO Device
4/4/2013 7:10:35 AM
More...
|
CryoLife, Inc. (CRY) Expands Stock Repurchase Program
2/14/2013 9:28:41 AM
More...
|
CryoLife, Inc. (CRY) 2012 Annual Revenues Grew to a Record $131.7 Million
2/14/2013 9:13:47 AM
More...
|
CryoLife, Inc. (CRY) Announces Quarterly Cash Dividend for the First Quarter 2013
2/13/2013 1:13:38 PM
More...
|
|